The average P/S ratio for TNDM's competitors is 78.56, providing a benchmark for relative valuation. Tandem Diabetes Care Inc Corp (TNDM) exhibits a P/S ratio of 0.99, which is -98.74% above the industry average. Given its robust revenue growth of 22.30%, this premium appears sustainable.